TruBridge (TBRG) AI Stock Analysis

• Market Cap: $288.37M
• Dividend Yield: N/A
• Average Volume (3M): 110.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.55
• Revenue Growth: 3.75%
• EPS Growth: N/A
• Country: US
• Employees: 3,200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.88
• Shares Outstanding: 15,011,642
• 10 Day Avg. Volume: 98,314
• 30 Day Avg. Volume: 110,375
• PEG Ratio: 0.25
• Price to Book (P/B): 1.67
• Price to Sales (P/S): 0.82
• P/FCF Ratio: 21.63
• Enterprise Value/Market Cap: 1.72
• Enterprise Value/Revenue: 1.42
• Enterprise Value/Gross Profit: 2.67
• Enterprise Value/Ebitda: 9.25
• 1Y Price Target: $21.00
• Price Target Upside: -8.02% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: $24.50 ▲(7.31% Upside)

TruBridge's strong revenue growth and improved cash flow are significant positives, but profitability concerns and high valuation weigh on the overall score. The technical indicators are favorable, and recent corporate events enhance financial flexibility, supporting future growth prospects.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand for TruBridge's services, enhancing its market position and long-term business prospects.

Cash Generation

Significant free cash flow growth demonstrates TruBridge's ability to generate cash, supporting reinvestment and debt reduction efforts.

Financial Flexibility

The increased credit facility enhances financial flexibility, positioning TruBridge for strategic growth and operational resilience.

Negative Factors

Profitability Challenges

Negative net profit margins highlight ongoing challenges in converting revenue into profit, potentially impacting long-term sustainability.

Underwhelming Bookings

Declining bookings suggest potential issues in sales execution or market demand, which could affect future revenue streams.

Leadership Change

Leadership changes can disrupt strategic continuity, impacting TruBridge's ability to maintain client relationships and drive growth.

TruBridge Business Overview & Revenue Model

Company Description

TruBridge (TBRG) is a leading provider of innovative healthcare solutions, specializing in revenue cycle management (RCM), technology, and consulting services. The company focuses on enhancing operational efficiency for healthcare providers, including hospitals and outpatient facilities, through its advanced software solutions and dedicated support teams. TruBridge aims to streamline billing processes, improve patient engagement, and ensure compliance with regulatory standards, making it a vital partner in the healthcare sector.

How the Company Makes Money

TruBridge generates revenue primarily through its comprehensive suite of revenue cycle management services, which include billing, coding, collections, and financial reporting for healthcare providers. The company earns money by charging clients a percentage of the collections made from their patient accounts, often structured as a fee-for-service model. Additionally, TruBridge offers software solutions on a subscription basis, allowing healthcare organizations to utilize its technology for managing their operations more effectively. Key revenue streams also include consulting services aimed at optimizing financial performance and compliance. The company might form strategic partnerships with healthcare organizations and technology providers, enhancing its service offerings and expanding its client base, which contributes significantly to its overall earnings.

TruBridge Financial Statement Overview

Summary

TruBridge exhibits strong revenue growth and improved cash flow generation, positioning it well for future expansion. However, profitability remains a concern with negative net margins and return on equity. The company's balance sheet shows reduced leverage, enhancing financial stability. Continued focus on improving profitability and operational efficiency will be crucial for sustaining growth.

Income Statement

TruBridge has shown a strong revenue growth rate of 65.5% in the TTM, indicating robust top-line expansion. However, the net profit margin remains negative at -1.59%, reflecting challenges in converting revenue growth into profitability. The gross profit margin is healthy at 57.67%, suggesting efficient cost management. EBIT and EBITDA margins are moderate at 5.55% and 7.83%, respectively, indicating room for improvement in operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has significantly improved to 0.025 in the TTM, indicating reduced leverage and a stronger balance sheet. However, the return on equity is negative at -4.37%, highlighting profitability challenges. The equity ratio stands at 45.16%, suggesting a stable capital structure with a reasonable proportion of equity financing.

Cash Flow

TruBridge has achieved a substantial free cash flow growth rate of 43.05% in the TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is high at 192.08, indicating efficient cash conversion. However, the free cash flow to net income ratio is relatively low at 0.21, suggesting potential reinvestment or debt repayment needs.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	349.88M	342.65M	339.44M	326.65M	280.63M	264.49M
Gross Profit	185.99M	174.12M	163.57M	160.11M	144.85M	136.25M
EBITDA	53.72M	34.94M	-15.39M	47.73M	43.11M	35.56M
Net Income	5.58M	-20.44M	-45.79M	15.87M	18.43M	14.25M
Balance Sheet
Total Assets	399.41K	394.43M	431.78M	430.96M	383.35M	326.27M
Cash, Cash Equivalents and Short-Term Investments	19.92K	12.32M	3.85M	6.95M	11.43M	12.67M
Total Debt	4.57K	174.81M	203.29M	147.24M	106.46M	83.43M
Total Liabilities	219.05K	225.74M	247.80M	199.25M	160.78M	126.27M
Stockholders Equity	180.36K	168.69M	183.97M	231.71M	222.57M	200.00M
Cash Flow
Free Cash Flow	29.43M	13.04M	-22.35M	13.01M	37.46M	42.48M
Operating Cash Flow	38.40M	32.13M	1.06M	32.38M	47.74M	49.14M
Investing Cash Flow	-12.63M	4.12M	-60.11M	-62.73M	-69.92M	-6.66M
Financing Cash Flow	-14.44M	-27.74M	55.95M	25.88M	20.93M	-37.16M

TruBridge Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.83
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Positive. The current price of 22.83 is above the 20-day moving average (MA) of 22.00, above the 50-day MA of 20.62, and below the 200-day MA of 22.85, indicating a neutral trend. The MACD of 0.71 indicates Positive momentum. The RSI at 62.61 is Neutral, neither overbought nor oversold. The STOCH value of 37.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TBRG.

TruBridge Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPOK	72 Outperform	$271.48M	16.47	10.88%	9.58%	1.47%	11.33%
TBRG	64 Neutral	$288.37M	-22.76	1.57%	―	3.75%	―
SLP	62 Neutral	$395.64M	―	-42.13%	―	13.09%	-745.95%
OPRX	61 Neutral	$259.29M	―	0.03%	―	24.19%	―
NRC	59 Neutral	$359.57M	22.52	66.01%	2.84%	-3.50%	-37.46%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HCAT	50 Neutral	$186.73M	―	-31.33%	―	4.64%	-17.17%

TruBridge Corporate Events

TruBridge Enhances Credit Facility for Growth

On November 25, 2025, TruBridge entered into an Amended and Restated Credit Agreement, increasing its revolving credit facility to $180 million and its term loan facility to $70 million. The agreement, which extends the maturity date to November 2030, enhances TruBridge’s financial flexibility and positions the company for future growth, as stated by CFO Vinay Bassi. This move reflects TruBridge’s disciplined capital allocation strategy aimed at delivering higher value for stakeholders.

TruBridge Appoints New Chief Business Officer

On October 1, 2025, TruBridge announced that Dawn M. Severance would step down as Chief Sales Officer by October 31, 2025, following the company’s decision to eliminate the position. Her departure is amicable and not due to any disagreements, and she will receive severance benefits as per her agreement. On October 3, 2025, TruBridge appointed Michael Daughton as Chief Business Officer, effective October 6, 2025, to enhance client-centered excellence and growth. Daughton, with 30 years of strategic healthcare leadership experience, is expected to drive shareholder value and reinforce TruBridge’s commitment to rural and community healthcare.